Recombinant Human Probable G-protein coupled receptor 174 (GPR174)

What is GPR174 and what cellular systems express this receptor?

GPR174 belongs to the G protein-coupled receptor superfamily characterized by seven alpha-helical transmembrane domains. It was initially classified as an orphan receptor but is now known to respond to lysophosphatidylserine (LysoPS). The gene encoding GPR174 is located on chromosome Xq21.1 and contains 4 exons .

GPR174 is abundantly expressed in both B and T lymphocytes, making it particularly relevant for immunological research . Expression analysis reveals significant presence in thymic tissue, peripheral lymphoid organs, and regulatory T cells. When studying expression patterns, researchers should consider using flow cytometry with validated antibodies or transcript analysis via RT-qPCR to avoid cross-reactivity issues with related GPCRs.

What are the known ligands for GPR174 and their binding mechanisms?

Lysophosphatidylserine (LysoPS) has been identified as the primary ligand for GPR174. Structural studies have revealed that LysoPS binding to GPR174 involves several key interactions:

• The phosphate group of LysoPS interacts with K98^3.32^, R75^2.60^, R156^4.64^, and K257^6.62^ in GPR174

• The amino group of the serine in LysoPS forms a hydrogen bond with Y79^2.64^ in GPR174

• The hydrophobic tail's orientation is determined by the arrangement of TM4 and TM5, particularly influenced by P153^4.61^ and P197^5.50^

Compared to other LysoPS receptors like GPR34, GPR174 forms more charged interactions with the polar head of LysoPS, suggesting potentially tighter binding . For experimental approaches, researchers should consider using LysoPS (18:1) as it has been successfully used in structural studies.

Through which G protein pathways does GPR174 signal and what are the downstream effects?

GPR174 signals primarily through Gαs-containing heterotrimeric G proteins, as demonstrated by multiple lines of evidence:

• B cells lacking Gαs show a block in induction of the GPR174-dependent gene expression program

• GPR174 signaling leads to cAMP production, which typically has anti-inflammatory effects

• Structural studies have confirmed the formation of LysoPS-bound GPR174-Gs complexes

The downstream effects of GPR174 signaling in B cells include:

Importantly, GPR174-Gαs signaling reduces B cell viability in culture, suggesting a role in regulating lymphocyte survival . Researchers investigating GPR174 signaling should consider using protein kinase A inhibitors as controls, since spontaneous CD86 upregulation in cultured B cells is PKA-dependent.

How does GPR174 influence regulatory T cell biology and autoimmunity?

GPR174 plays a crucial role in constraining regulatory T cell (Treg) accumulation and activity. When studying GPR174's effects on Tregs, researchers should consider:

• Tissue specificity: Gpr174^-/Y^ mice show increased Foxp3^+^CD4^+^ single-positive (SP) cell frequencies in the thymus and colon lamina propria, but not in spleen and lymph nodes

• Cell-intrinsic effects: In mixed bone marrow chimeric mice, Gpr174^-/Y^ Foxp3^+^CD4^+^ SP thymocyte frequencies were significantly higher than those of Gpr174^-/Y^ DP and CD4 SP thymocytes, indicating cell-intrinsic regulation

• Signaling mechanisms: CD25^+^CD4^+^ SP thymocytes in Gpr174^-/Y^ mice express lower levels of Nur77-GFP, suggesting altered TCR signaling during development

GPR174 deficiency leads to enhanced Treg cell proliferation, as evidenced by increased Ki-67 expression in thymic Foxp3^+^CD4^+^ SP cells but not in Foxp3^-^CD4^+^ SP thymocytes . This suggests GPR174 may intrinsically constrain thymic Treg cell proliferation.

What role does GPR174 play in B cell function and how can this be experimentally assessed?

GPR174 significantly modulates B cell gene expression and survival in a G protein-dependent manner. Key experimental findings include:

• B cells undergo a spontaneous GPR174-dependent activation process during in vitro culture, associated with marked changes in gene expression

• Both GPR174- and Gαs-deficient B cells show enhanced survival in culture

• In vivo, GPR174 contributes to NUR77 expression in follicular B cells and is required for establishing a normal-sized marginal zone compartment

To experimentally assess GPR174 function in B cells, researchers can:

• Measure expression of GPR174-dependent genes (Cd86, Nr4a1, Ccr7) after culture

• Assess B cell viability in the presence/absence of GPR174 antagonists

• Use lysoPS treatment in vivo to promote CD86 upregulation by follicular B cells

• Examine marginal zone B cell development in Gpr174^-/Y^ mice

Importantly, treatment of mice with lysophosphatidylserine (lysoPS) is sufficient to promote CD86 upregulation by follicular B cells, providing a useful experimental approach to activate this pathway in vivo .

How are GPR174 variants associated with autoimmune conditions?

Variants in the GPR174 locus have been associated with multiple autoimmune diseases . Specifically:

• The GPR174 gene has been linked to Graves' disease susceptibility through genome-wide association studies

• The role of GPR174 in restraining T cell responses and modulating B cell function provides mechanistic insights into how alterations in GPR174 expression may contribute to autoimmunity

When studying these associations, researchers should consider that GPR174 is located on the X chromosome (Xq21.1), which may contribute to sex-based differences in autoimmune disease susceptibility. Experimental approaches should account for these potential sex differences in study design.

What methodological challenges exist in studying GPR174 function?

Several methodological challenges must be addressed when investigating GPR174:

• In vitro B cell culture limitations: During culture without stimulation, B cells undergo massive changes in gene expression promoted by GPR174 signaling via Gαs . Researchers should consider using GPR174 antagonists to reduce this shift in gene expression and augment B cell survival during culture.

• Ligand complexity: While LysoPS is established as a GPR174 ligand, the physiological regulation of LysoPS levels in different tissues remains poorly understood. Researchers should measure tissue LysoPS concentrations when interpreting GPR174 functions in different contexts.

• Receptor structure considerations: When designing binding studies, researchers should account for specific interactions in the binding pocket. The polar head of LysoPS makes more charged interactions with GPR174 than with GPR34, suggesting tighter binding that may affect experimental approaches .

How can researchers effectively produce and utilize recombinant GPR174 for structural and functional studies?

Structural studies of GPR174 have been successfully conducted using cryo-electron microscopy (cryo-EM). Key methodological considerations include:

• Use of an engineered G protein (mini-Gs) to facilitate complex formation and improve cryo-EM sample quality

• Modeling of LysoPS (18:1) into the density, with attention to the fact that the last 6 carbons of the oleic acid often lack density

• Comparing binding modes between related receptors (e.g., GPR34 vs. GPR174) to identify critical residues for ligand recognition

When expressing recombinant GPR174, researchers should consider:

• Expression systems that accommodate proper folding of seven-transmembrane domain proteins

• Addition of stabilizing mutations or fusion proteins to improve expression and stability

• Use of detergents or nanodiscs that maintain the native structure of the receptor

What are the current gaps in our understanding of GPR174 biology?

Despite significant advances, several important questions about GPR174 remain unanswered:

• The complete physiological role of GPR174 in different immune cell types and tissues

• The enzymatic pathways that regulate LysoPS production and degradation in vivo

• The potential cross-talk between GPR174 and other immunoregulatory receptors

• The mechanisms by which GPR174 variants contribute to autoimmune disease susceptibility

Researchers approaching these questions should consider multi-disciplinary approaches combining genetic models, structural biology, and systems immunology to obtain comprehensive insights into GPR174 biology.

How might targeting GPR174 be useful in therapeutic applications?

Given GPR174's role in immune regulation, targeting this receptor may have therapeutic potential:

• GPR174 antagonists may improve B cell survival during in vitro culture, enhancing experimental systems for studying B cell responses

• Since GPR174 constrains regulatory T cell accumulation and activity, modulating its function might be useful in autoimmune conditions where Treg activity is insufficient

• The anti-inflammatory effects of GPR174 signaling through Gαs (producing cAMP) suggest that GPR174 agonists might have utility in dampening excessive immune responses

When developing potential GPR174-targeting therapeutics, researchers should consider tissue specificity, potential off-target effects on related receptors, and the complex roles of GPR174 in different immune cell populations.